NEW YORK (GenomeWeb News) – SDIX, the firm previously known as Strategic Diagnostics, reported after the close of the market Thursday that its fourth-quarter revenues fell 11 percent, but the firm managed to cut its loss to almost zero for the quarter.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.